In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Smith & Nephew's Play in Image-Guided Surgery

Executive Summary

Quietly over the past several years, spinal implant leader Sofamor Danek (acquired by Medtronic Inc. ) has built a leadership position in image-guided surgery (IGS). The relevance to Sofamor Danek's core spinal business is clear: through enhanced visualization and navigation, spinal surgeons can perform complex cases that were once thought impossible and do more routine surgeries more quickly and easily. Now, Medtronic Sofamor Danek and Smith & Nephew PLC are teaming up to see if the benefits of IGS can extend to more traditional orthopedic segments.

You may also be interested in...



Smith & Nephew's Race to the Top

Guess who was the fastest growing orthopedic implant company last year. Smith & Nephew. The boom that has characterized the orthopedics market for the past several years has been a rising tide that lifts all boats--all, that is, except Smith & Nephew. But in the last couple of years, Smith & Nephew has actually been growing faster than their larger competitors. And in an industry that will increasingly see winners and losers, Smith & Nephew believes it is positioned to be one of the winners.

Smith & Nephew and Centerpulse: Perfect Together

While the deal between Smith & Nephew and Centerpulse may feel like the product of recent events, most notably Centerpulse's troubles, a closer look reveals the complementary nature of the two companies, showing the merger would have made sense in any case.

New Gavi Fund To Guarantee Global Market For COVID-19 Vaccines

The latest global vaccines summit has seen the launch of a new mechanism designed to spur the development of new coronavirus vaccines and ensure they are made available, particularly in low- and middle-income countries.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

CO218746

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel